Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

A preliminary report on (99m)Tc-fanolesomab imaging of renal allograft.

Aygen M, Amirmokri P, Berk F, Nguyen N, Bastani B, Civelek AC.

Nucl Med Commun. 2011 Oct;32(10):925-8. doi: 10.1097/MNM.0b013e328348c0fb.

PMID:
21862945
2.

Use of early postoperative MAG3 renal scan to predict long-term outcomes of renal transplants.

Park UJ, Kim HT, Cho WH, Kim MY, Hwang EA, Han SY, Park SB, Kim HC, Zeon SK.

Exp Clin Transplant. 2013 Apr;11(2):118-21. doi: 10.6002/ect.2012.0090. Epub 2013 Mar 11.

3.

Technetium-99m sulfur colloid accumulation as a predictor of acute renal transplant rejection.

Massengill SF, Pena DR, Drane WE, Fennell RS, Richard GA.

Transplantation. 1992 Dec;54(6):969-73.

PMID:
1465790
4.

99mTc-Labeled murine IgM monoclonal antibody, fanolesomab, that targets the CD15 glycoprotein antigen.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Sep 19 [updated 2011 Oct 28].

5.

Functional magnetic resonance imaging of human renal allografts during the post-transplant period: preliminary observations.

Szolar DH, Preidler K, Ebner F, Kammerhuber F, Horn S, Ratschek M, Ranner G, Petritsch P, Horina JH.

Magn Reson Imaging. 1997;15(7):727-35.

PMID:
9309603
6.

Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.

Höcker B, Tönshoff B.

Paediatr Drugs. 2009;11(6):381-96. doi: 10.2165/11316100-000000000-00000. Review.

PMID:
19877724
7.

Development of chronic injury and nature of interstitial infiltrate in a model of chronic renal allograft rejection.

Stein-Oakley AN, Jablonski P, Tzanidis A, Baxter K, Howden BO, Marshall VC, Thomson NM.

Transplantation. 1993 Dec;56(6):1299-305.

PMID:
8278992
8.

[Evaluation of the rate of progression of chronic renal transplant rejection using the proliferating cell nuclear antigen ].

Simić-Ogrizović S, Starcević-Bozović A, Blagojević R, Radivojević D, Djkanović L.

Srp Arh Celok Lek. 2002 May-Jun;130(5-6):159-64. Serbian.

9.
10.

Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries.

Aita K, Yamaguchi Y, Shimizu T, Horita S, Furusawa M, Tanabe K, Fuchinoue S, Toma H.

Clin Transplant. 2004;18 Suppl 11:7-12.

PMID:
15191366
11.

Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts.

Messias NC, Eustace JA, Zachary AA, Tucker PC, Charney D, Racusen LC.

Transplantation. 2001 Aug 27;72(4):655-60.

PMID:
11544426
12.

Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections.

Naderi GH, Mehraban D, Ganji MR, Yahyazadeh SR, Latif AH.

Urol J. 2009 Winter;6(1):31-4.

13.

[Clinical significance of early diagnose and treatment of subclinical renal allograft rejection].

Zeng JH, Yu LX, Luo HH, Wang XC, Wang X, Fang W.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 May;26(5):697-8. Chinese.

PMID:
16762888
14.

HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.

Lee PC, Zhu L, Terasaki PI, Everly MJ.

Transplantation. 2009 Aug 27;88(4):568-74. doi: 10.1097/TP.0b013e3181b11b72.

PMID:
19696641
15.

Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.

Woodle ES, Xu D, Zivin RA, Auger J, Charette J, O'Laughlin R, Peace D, Jollife LK, Haverty T, Bluestone JA, Thistlethwaite JR Jr.

Transplantation. 1999 Sep 15;68(5):608-16.

PMID:
10507477
16.

Kidney allograft outcome in simultaneous pancreas-kidney transplantation.

Nakache R, Weinbroum A, Merhav H, Kaplan E, Kariv Y, Khoury W, Gutman M, Klausner JM.

Isr Med Assoc J. 2000 Jul;2(7):517-9.

PMID:
10979325
17.

Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.

Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SI.

Transplant Proc. 2005 Mar;37(2):737-42.

PMID:
15848518
18.

[Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].

Wu JY, Chen JH, Wang YM, Zhang JG, Zhu C, Wang SY, Zhang P, Huang HF, He Q.

Zhonghua Yi Xue Za Zhi. 2003 Jan 25;83(2):106-9. Chinese.

PMID:
12812676
19.

Radiotherapy for rejection of renal transplant allografts refractory to medical immunosuppression.

Wahl AO, Small W Jr, Dixler I, Strom S, Rademaker A, Leventhal J, Abecassis MM.

Am J Clin Oncol. 2006 Dec;29(6):551-4.

PMID:
17148990
20.

(99m)Tc-labeled murine ior C5 monoclonal antibody in colorectal carcinoma patients: pharmacokinetics, biodistribution, absorbed radiation doses to normal organs and tissues and tumor localization.

Iznaga-Escobar N, Ramos-Suzarte M, Morales-Morales A, Torres-Arocha L, Rodríguez-Mesa N, Pérez-Rodriguez R.

Methods Find Exp Clin Pharmacol. 2004 Nov;26(9):687-96.

PMID:
15632954

Supplemental Content

Support Center